Increase in motor neuron disease mortality in Spain: Temporal and geographical analysis (1990–2005)

References

• Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369:2031–41.
   PubMed Web of Science ®Google Scholar
• Uccelli R, Binazzi A, Altavista P, Belli S, Comba P, Mastrantonio M, . Geographic distribution of amyotrophic lateral sclerosis through motor neuron disease mortality data. Eur J Epidemiol. 2007;22:781–90.
   PubMed Web of Science ®Google Scholar
• Worms PM. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci. 2001;191:3–9.
   PubMed Web of Science ®Google Scholar
• Fang F, Valdimarsdóttir U, Bellocco R, Ronnevi LO, Sparén P, Fall K, . Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol. 2009;66:515–9.
   PubMed Web of Science ®Google Scholar
• Gunnarsson LG, Lindberg G, Söderfelt B, Axelson O. The mortality of motor neuron disease in Sweden. Arch Neurol. 1990;47:42–6.
   PubMed Web of Science ®Google Scholar
• Veiga-Cabo J, Almazán-Isla J, Sendra-Gutiérrez JM, de Pedro-Cuesta J. Differential features of motor neuron disease mortality in Spain. Int J Epidemiol. 1997;26:1024–32.
   PubMed Web of Science ®Google Scholar
• Maasilta P, Jokelainen M, Löytönen M, Sabel CE, Gatrell AC. Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand. 2001;104:232–5.
   PubMed Web of Science ®Google Scholar
• Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology. 2005;64: 1215–21.
   PubMed Web of Science ®Google Scholar
• Day TG, Scott M, Perring R, Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975–2004. Amyotroph Lateral Scler. 2007; 8:337–42.
   PubMed Web of Science ®Google Scholar
• Neilson S, Robinson I, Alperovitch A. Rising amyotrophic lateral sclerosis mortality in France, 1968–1990: increased life expectancy and inter-disease competition as an explanation. J Neurol. 1994;241:448–55.
   PubMed Web of Science ®Google Scholar
• Gil J, Funalot B, Torny F, Lacoste M, Couratier P. Exogenous risk factors in sporadic ALS: a review of the literature. Rev Neurol (Paris). 2007;163:1021–30.
   Google Scholar
• Beleza-Meireles A, Al-Chalabi A. Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives. Amyotroph Lateral Scler. 2009;10:1–14.
   PubMed Web of Science ®Google Scholar
• Matías-Guíu J, Galán L, García-Ramos R, Vela A, Guerreo A. Epidemiología descriptiva de la esclerosis lateral amiotrófica. Neurología. 2007;22:368–80.
   Google Scholar
• Velleman PF. Definition and comparison of robust non-linear data smoothing algorithms. J Am Statist Assoc. 1980;75:609–15.
   Web of Science ®Google Scholar
• Besag J, York JC, Mollié A. Bayesian image restoration, with two applications in spatial statistics (with discussion). Ann Inst Statist Math. 1991;43:1–59.
   Web of Science ®Google Scholar
• Neilson S, Robinson I, de Pedro-Cuesta J, Veiga-Cabo J. Decline and rise of mortality from motor neuron disease in Spain, 1960–1989: demographic, environmental and competitive influences. Neuroepidemiology. 1996;15: 180–91.
   PubMedGoogle Scholar
• Llorca Díaz J, Prieto Salceda MD, Delgado-Rodríguez M. Análisis del efecto de cohorte en la evolución de la mortalidad por enfermedad de la motoneurona en España, 1951–1992. Rev Esp Salud Pública. 1999;73:48l–8.
   Google Scholar
• Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology. 2000;55:1262–6.
   PubMed Web of Science ®Google Scholar
• Berlowitz DJ, Detering K, Schachter L. A retrospective analysis of sleep quality and survival with domiciliary ventilatory support in motor neuron disease. Amyotroph Lateral Scler. 2006;7:100–6.
   PubMed Web of Science ®Google Scholar
• Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889–95.
   PubMed Web of Science ®Google Scholar
• The Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992; 55:536–41.
   PubMed Web of Science ®Google Scholar
• Durlleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes real? Neurology. 1989;39;768–73.
   Google Scholar
• Sejvar JJ, Holman RC, Breesee JS, Kochanek KD, Schoenberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979–2001. Neuroepidemiology. 2005; 25:144–52.
   PubMed Web of Science ®Google Scholar
• Forbes RB, Colville S, Swingler RJ, Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or above. Age Ageing. 2004;33:131–4.
   PubMed Web of Science ®Google Scholar
• Zaldivar T, Gutierrez J, Lara G, Carbonara M, Logroscino G, Hardiman O. Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study. Neurology. 2009;72:1640–5.
   PubMed Web of Science ®Google Scholar
• National Statistics Institute of Spain (Instituto Nacional de Estadística). Localización y Especialización de la Industria [Internet]. Panorámica de la Industria. 2010 [cited 2010 Jun]. Available from: http://www.ine.es/prodyser/pubweb/pan_ind/INDweb.pdf.
   Google Scholar
• Cronin S, Hardiman O, Traynor BJ. Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007; 68:1002–7.
   PubMed Web of Science ®Google Scholar
• Landers JE, Melki J, Meininger V, Glass JD, van den Berg LH, van Es MA, . Reduced expression of the kinesin-associated protein 3 (KIFAP3) gene increases survival in amyotrophic lateral sclerosis. PNAS. 2009;106: 9004–9.
   PubMed Web of Science ®Google Scholar
• Morahan JM, Yu B, Trent RJ, Pamphlett R. Genetic susceptibility to environmental toxicants in ALS. Am J Med Genet. 2007;144:885–90.
   Google Scholar
• Armon C. An evidence-based medicine approach to the evaluation of the role of exogenous risk factors in sporadic amyotrophic lateral sclerosis. Neuroepidemiology. 2003;22:217–28.
   PubMed Web of Science ®Google Scholar
• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health. 1992;46:517–8.
   PubMed Web of Science ®Google Scholar
• Douglass CP, Kandler RH, Shaw PJ, McDermott CJ. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry. 2010;81:646–9.
   PubMed Web of Science ®Google Scholar
• Nygren I, Antonova K, Mattsson P, Askmark H. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics. Acta Neurol Scand. 2005;111:180–4.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124 (Suppl):96–107.
   PubMed Web of Science ®Google Scholar